Rett, Syndrome

Rett Syndrome Market Sees Momentum with Novel Gene and Protein-Targeted Therapies | DelveInsight

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+14699457679

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/rett-syndrome-market-sees-momentum-with-novel-gene-and-protein-targeted-therapies--delveinsight-302465000.html

en | boerse | 67933915 |